Results 41 to 50 of about 21,846 (223)

Correlation between bullous pemphigoid and type 2 inflammation

Pifu-xingbing zhenliaoxue zazhi, 2022
Bullous pemphigoid (BP) is one of the common autoimmune blister diseases that mainly affects the elderly. Most bullous pemphigoid patients have obvious symptom of pruritus, accompanied by elevated levels of serum total IgE, peripheral blood eosinophils ...
Yao ZHOU, Guomin LI, Zhijun XU, Jie XU, Jinjin ZHENG, Hao FANG, Ruzeng XUE   +6 more
doaj   +1 more source

Bullous Pemphigoid Complicated by Sepsis

, 2022
Patients with bullous pemphigoid face many challenges when managing their disorder, one of which is balancing medication with their ailments. Because the patient population with bullous pemphigoid are primarily elderly, the current first-line treatment ...
Falgiani, Michael, Shah, Dipal, Nguyen, Viet S, Ganti, Latha, Shah, Aanchal   +4 more
core   +1 more source

Lower Extremity Salvage in the Setting of Bullous Pemphigoid Exacerbation: A Case Report

Plastic and Reconstructive Surgery, Global Open, 2021
Summary:. Bullous pemphigoid is an autoimmune blistering disease where patients suffer from painful bullae, often covering large portions of the skin and requiring management with immune-suppression.
Samara E. Pollock, MD, Shauna M. Rice, BS, Sarah D. Ferree, MD, Jonathan Friedstat, MD, MPH, Kyle Eberlin, MD, Arianne S Kourosh, MD MPH   +5 more
doaj   +1 more source

A Systematic Review of Drug-Induced Pemphigoid

Acta Dermato-Venereologica, 2020
Bullous pemphigoid is an autoimmune subepithelial disease characterised by pruritus followed by urticarial plaques and finally bullae on the skin and mucosa.
Matthew J. Verheyden, Asli Bilgic, Dédée F. Murrell   +2 more
doaj   +1 more source

Bullous pemphigoid and comorbidities: a case-control study in Portuguese patients [PDF]

Anais Brasileiros de Dermatologia, 2014
BACKGROUND: aAlthough rare, bullous pemphigoid (BP) is the most common autoimmune blistering disease. Recent studies have shown that patients with bullous pemphigoid are more likely to have neurological and psychiatric diseases, particularly prior to the
Vera Barreto Teixeira, Rita Cabral, Maria Manuel Brites, Ricardo Vieira, Américo Figueiredo   +4 more
doaj   +1 more source

Safety outcomes of antidiabetic medications: A comprehensive review of the EU summaries of product characteristics and international clinical practice guidelines

British Journal of Clinical Pharmacology, EarlyView.
Aims Information on the safety profile of antidiabetic medications is essential for informed treatment decisions in type 2 diabetes mellitus. Although this information is available in regulatory documents of individual drugs, a comprehensive overview across all approved antidiabetics is lacking.
David Liang, Daniala L. Weir, Safana Thevasahayam, Vera H. M. Deneer, Arno Siebes, Helga Gardarsdottir   +5 more
wiley   +1 more source

Bullous pemphigoid: therapeutic algrorithm and practical management [PDF]

, 2013
Introduction: Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease of the skin and mucosae. BP typically affects the elderly and manifests with severe itch, localised or generalised eczematous, urticated and/or bullous ...
Borradori, Luca, Daniel, Benjamin S., Murrell, Dedee F.   +2 more
core   +1 more source

A case report of bullous pemphigoid following secukinumab therapy for a patient with psoriasis

Journal of Dermatological Treatment
Aim: Bullous pemphigoid induced by secukinumab in treatment of psoriasis is rare.Methods: We report a 49-year-old man with psoriasis who developed bullous pemphigoid during treatment with secukinumab.Results: Scattered tense vesicles with itching ...
Guanghan Wang, Xiaojing Hu, Shixin Han, Meijuan Zhou   +3 more
doaj   +1 more source

Pemphigoid gestationis and intravenous immunoglobulin therapy

International Journal of Women's Dermatology, 2018
Pemphigoid gestationis, which is also known as herpes gestationis, is a rare, pregnancy-associated, autoimmune bullous disease. Treatment depends on the severity of the disease for each patient and the safety and use of these drugs during pregnancy and ...
Anes Yang, MD, BMed, MPH, Elizabeth Uhlenhake, MD, FAAD, Dedee F. Murrell, MA, BMBCh, FAAD, MD, FACD, FRCP   +2 more
doaj   +1 more source

Dipeptidyl Peptidase‐4 Inhibitor Use and Risk of Pemphigus Vulgaris and Foliaceus: A Retrospective Cohort Study Using Databases of the Korea National Health Insurance Claims and the National Health Screening Examination

The Journal of Dermatology, EarlyView.
ABSTRACT Although population‐based studies have reported an increased risk of bullous pemphigoid and pemphigus associated with dipeptidyl peptidase‐4 (DPP‐4) inhibitors, there is limited, well‐designed epidemiological evidence for pemphigus vulgaris (PV), which has only been supported by case reports thus far.
Jaein Lee, Jae Hyun Bae, Seokyung Hahn
wiley   +1 more source